Abalone Bio
Lauren Schwimmer is a Vice President of Preclinical Development at Abalone Bio since November 2020. Prior to this, Lauren was the Director of Antibody Discovery and Engineering at QLSF Biotherapeutics, Inc. from September 2018 to November 2020. Before that, Lauren was the Director of Antibody Discovery at Distributed Bio Inc from October 2016 to July 2018 and the Associate Director of Antibody Discovery and Engineering at XOMA from October 2008 to September 2016. Schwimmer has a PhD in Biochemistry from Georgia Institute of Technology and a BS in Chemistry from Butler University.
This person is not in any offices
Abalone Bio
Abalone Bio develops antibody drugs that activate, enabling us to turn on previously inaccessible biological activities like anti-cancer or anti-inflammatory actions.